(VIANEWS) – SALMAR (SALM.OL), OCI (OCI.AS), BAM GROEP KON (BAMNB.AS) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| SALMAR (SALM.OL) | 6.35% | 2024-09-06 08:42:43 |
| OCI (OCI.AS) | 5.94% | 2024-09-06 08:03:12 |
| BAM GROEP KON (BAMNB.AS) | 5.3% | 2024-09-06 08:00:47 |
| AIB GROUP PLC (A5G.IR) | 5.03% | 2024-09-06 08:22:08 |
| FERM.CAS.MUN.CANNE (FCMC.PA) | 5% | 2024-09-01 11:48:10 |
| SANOFI (SAN.PA) | 3.72% | 2024-09-01 12:02:11 |
| EQUASENS (EQS.PA) | 2.62% | 2024-09-01 11:47:28 |
Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. SALMAR (SALM.OL)
6.35% Foward Dividend Yield
SALMAR’s last close was kr540.00, 24.75% under its 52-week high of kr717.60. Intraday change was -0.73%.
SalMar ASA, an aquaculture company, produces and sells farmed salmon in Asia, North America, Europe, and internationally. The company operates through Fish Farming Central Norway, Fish Farming Northern Norway, Icelandic Salmon, Sales & Industry, and SalMar Aker Ocean segments. It is involved in the broodstock, harvesting, processing, and smolt production activities. In addition, the company offers fish fillets and related products. SalMar ASA was founded in 1991 and is headquartered in Kverva, Norway.
Earnings Per Share
As for profitability, SALMAR has a trailing twelve months EPS of kr27.33.
PE Ratio
SALMAR has a trailing twelve months price to earnings ratio of 19.81. Meaning, the purchaser of the share is investing kr19.81 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.68%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SALMAR’s stock is considered to be oversold (<=20).
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jun 7, 2024, the estimated forward annual dividend rate is 35 and the estimated forward annual dividend yield is 6.35%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 272.3% and 45.3%, respectively.
Volatility
SALMAR’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.25%, a negative 0.41%, and a positive 1.28%.
SALMAR’s highest amplitude of average volatility was 1.61% (last week), 1.45% (last month), and 1.28% (last quarter).
More news about SALMAR.
2. OCI (OCI.AS)
5.94% Foward Dividend Yield
OCI’s last close was €28.38, 2.57% below its 52-week high of €29.13. Intraday change was -0.18%.
OCI N.V. produces and distributes hydrogen-based and natural gas-based products to agricultural, transportation, and industrial customers. It operates through Methanol US, Methanol Europe, and Nitrogen Europe segments. The company offers anhydrous ammonia, granular urea, urea ammonium nitrate solution, calcium ammonium nitrate, ammonium sulphate, ammonium nitrate + sulphur, renewable and lower carbon ammonia, nitric acid, bio-methanol, methanol, melamine, carbon dioxide, and diesel exhaust fluid, as well as other nitrogen products. It also provides storage and shipment services for ammonia at the port of Rotterdam. The company has operations in Europe, the Americas, the Middle East, Africa, Asia, and Oceania. OCI N.V. was founded in 2013 and is headquartered in Amsterdam, the Netherlands.
Earnings Per Share
As for profitability, OCI has a trailing twelve months EPS of €-3.14.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -19.5%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Oct 26, 2023, the estimated forward annual dividend rate is 1.7 and the estimated forward annual dividend yield is 5.94%.
More news about OCI.
3. BAM GROEP KON (BAMNB.AS)
5.3% Foward Dividend Yield
BAM GROEP KON’s last close was €3.55, 19.32% below its 52-week high of €4.40. Intraday change was -0.77%.
Koninklijke BAM Groep nv, together with its subsidiaries, provides products and services in the construction and property, civil engineering, and public private partnerships (PPP) sectors worldwide. The company engages in residential construction projects, and non-residential construction activities. It is also involved in rail infrastructure and facilities management activities. Koninklijke BAM Groep nv was founded in 1869 and is headquartered in Bunnik, the Netherlands.
Earnings Per Share
As for profitability, BAM GROEP KON has a trailing twelve months EPS of €0.62.
PE Ratio
BAM GROEP KON has a trailing twelve months price to earnings ratio of 5.81. Meaning, the purchaser of the share is investing €5.81 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19%.
More news about BAM GROEP KON.
4. AIB GROUP PLC (A5G.IR)
5.03% Foward Dividend Yield
AIB GROUP PLC’s last close was €5.28, 4.52% below its 52-week high of €5.53. Intraday change was 0.09%.
AIB Group plc provides banking and financial products and services to retail, business, and corporate customers in the Republic of Ireland and the United Kingdom. It operates through Retail Banking, AIB Capital Markets, and AIB UK, and Group segments. The company offers current and savings accounts, demand deposits, notice deposits, fixed term deposits, junior/student saver deposits, and currency deposits. It also provides personal, car, home improvement, education, business, farm development, startup, farm investment, future growth, and brexit loans; graduate, corporate, asset, energy efficiency, forestry, invoice, prompt pay and insurance premium, debt, real estate, and trade finance; business and farmer credit line, government credit guarantees, and overdrafts; and venture capital funds, as well as mortgages. In addition, the company offers credit and debit cards; investment funds; life, home, car, travel, and business succession insurance products; and pension products. Further, it provides payment, merchant, cash management, FX rates, foreign currency and interest rate risk management, exporting, international cash flow management, foreign exchange, and interest rate fluctuation management services; and trade finance products, such as documentary collections, import and export letter of credit, standby letter of credit, and bank guarantees. The company was formerly known as Allied Irish Banks, p.l.c. and changed its name to AIB Group plc in December 2017. AIB Group plc was founded in 1825 and is headquartered in Dublin, Ireland.
Earnings Per Share
As for profitability, AIB GROUP PLC has a trailing twelve months EPS of €0.87.
PE Ratio
AIB GROUP PLC has a trailing twelve months price to earnings ratio of 6.17. Meaning, the purchaser of the share is investing €6.17 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.08%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AIB GROUP PLC’s stock is considered to be overbought (>=80).
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Mar 21, 2024, the estimated forward annual dividend rate is 0.27 and the estimated forward annual dividend yield is 5.03%.
Volume
Today’s last reported volume for AIB GROUP PLC is 1440870 which is 66.45% below its average volume of 4295630.
Revenue Growth
Year-on-year quarterly revenue growth grew by 14.8%, now sitting on 4.83B for the twelve trailing months.
More news about AIB GROUP PLC.
5. FERM.CAS.MUN.CANNE (FCMC.PA)
5% Foward Dividend Yield
FERM.CAS.MUN.CANNE’s last close was €1,500.00, 14.29% below its 52-week high of €1,750.00. Intraday change was 0%.
Société Fermière du Casino Municipal de Cannes operates casinos and hotels in France. The company operates hotels and cottages under the Hôtel Barrière Le Majestic, the Hôtel Barrière Le Gray d'Albion, and the Hôtel Barrière Le Carl Gustaf St-Barth brands. It also operates casinos, slot machines, and games tables under the Casino Barrière Croisette and Casino Barrière Les Princes brands. In addition, the company operates restaurants, bars, and spa. Société Fermière du Casino Municipal de Cannes was founded in 1919 and is based in Cannes, France.
Earnings Per Share
As for profitability, FERM.CAS.MUN.CANNE has a trailing twelve months EPS of €60.1.
PE Ratio
FERM.CAS.MUN.CANNE has a trailing twelve months price to earnings ratio of 26.46. Meaning, the purchaser of the share is investing €26.46 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.3%.
More news about FERM.CAS.MUN.CANNE.
6. SANOFI (SAN.PA)
3.72% Foward Dividend Yield
SANOFI’s last close was €104.54, 0.21% above its 52-week high of €104.32. Intraday change was -0.87%.
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SANOFI has a trailing twelve months EPS of €4.3.
PE Ratio
SANOFI has a trailing twelve months price to earnings ratio of 21.15. Meaning, the purchaser of the share is investing €21.15 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.82%.
More news about SANOFI.
7. EQUASENS (EQS.PA)
2.62% Foward Dividend Yield
EQUASENS’s last close was €45.50, 40.91% below its 52-week high of €77.00. Intraday change was -0.39%.
Equasens Société anonyme provides healthcare IT solutions in Europe. It offers id. PATIENT, a business software; id. MOBILITY, a back-office management software; pandaLAB Pro, an instant messaging solution; Id. VENTE, an HAS-certified drug database; Id. COMMANDE, an order management module; dispensing robots; Services Ségur id; id. DOSAGE, a dosage management and printing module; multimeds reconditioning robot; compliance monitoring module; home delivery module; home equipment rental management module; Visiodroits module; and Website connector. The company also provides id. DESK, an informative and interactive dashboard; id. UP!, a real-time monitoring and control application of id management software; id. EASYQ, a queue management solution; Miaterapia; Id. SHOW, an application for managing real-time communications on pharmacy screens; Pharmaweb; TsGatePro; LMO, a dispensary business software; and LGO, a dispensary management software. In addition, it offers DOMILINK HAD software; mobiSOINS mobility tool; MEMORialis, support software for alzheimer's monitoring teams; HOSPILINK, an hospital information system applications; HOSPILINK DPI, a computerized patient file; HOSPILINK LOOKUP Big Data; eNephro solutions; NOVIAcare solutions; KAP&LINK2, a contact chip card reader terminal and NFC reader; eS-KAP-Ad, a connected nomadic tool incorporating software; KAP-INSIDE, a mobile terminal; and TI-KAP allowing access to contact and contactless cards. Further, the company provides AUTHENTICATOR, a patented authentication system; KAP'TEUR by KAPELSE, a patented universal sensor; ExpressVitale; MédiStory, that automates the transfer of invoicing to the healthcare professional's accounting. Additionally, it offers medical telesecretarial services for healthcare professionals, as well as equipment lease financing solutions. The company was incorporated in 1996 and is headquartered in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.
Earnings Per Share
As for profitability, EQUASENS has a trailing twelve months EPS of €3.2.
PE Ratio
EQUASENS has a trailing twelve months price to earnings ratio of 16.03. Meaning, the purchaser of the share is investing €16.03 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.04%.
More news about EQUASENS.
